Announcement on Voluntary Disclosure on the Acceptance of the Clinical Trial Application for the Investigational New Drug YXC-002

About this update from Shanghai Yizhong Pharmaceutical Co. Ltd. Class A

Announcement on Voluntary Disclosure on the Acceptance of the Clinical Trial Application for the Investigational New Drug YXC-002 The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Shanghai Yizhong Pharmaceutical Co. Ltd. Class A